State Health Commissioner Dr. James McDonald has emphasized the importance of protecting infants from respiratory syncytial virus (RSV), highlighting two main preventive measures available. According to Dr. McDonald, “I want to remind everyone that there are two effective ways to protect infants against respiratory syncytial virus (RSV). Nirsevimab is a one-time injection that protects your baby throughout the entire RSV season. Another option is for pregnant persons to receive the maternal vaccine before giving birth. While there is no specific medicine to treat RSV, a leading cause of infant hospitalizations, we are fortunate to have two safe and effective options to help prevent severe RSV illness in babies.”
Dr. McDonald referenced national data from the Centers for Disease Control and Prevention indicating that, with broader use of both the maternal vaccine and nirsevimab, hospitalization rates for infants due to RSV were reduced by up to 43 percent compared to previous years. He stated, “These preventive tools are helping protect our youngest New Yorkers during a time when they are most vulnerable.”
To improve access to vaccination, Dr. McDonald noted, “In 2024, I issued a statewide standing order allowing pharmacists in New York State to administer the RSV vaccine to make it easier for eligible individuals to get vaccinated. This includes adults 75 years and older, people 60-75 with underlying medical conditions and pregnant people.”
He also reminded the public about basic prevention practices: “No one wants their baby to be sick. Everyone can help reduce the spread of RSV by covering your mouth when coughing or sneezing, washing your hands and staying home from school or work when sick.”
